Clinical Trials Logo

Clinical Trial Summary

Inflammatory aortitis probably represents a heterogeneous group, and the clinical experience accumulated over the last ten years, shared by the experts of the subject, is that the initial clinical, biological or radiological characteristics should make it possible to differentiate them and dismember the Nosological field.

This will be an essential first step before studying prognosis, risk factors, and therapeutic options.

The search for diagnostic criteria on a large series, similar to the study of classification of vascularites of the ACR in 1990, should make it possible to homogenize the diagnoses for the different teams working on the subject, and to begin work Collaborations, which alone can improve patient care in the future.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03133949
Study type Observational
Source Centre Hospitalier Universitaire, Amiens
Contact Jean SCHMIDT, PhD
Phone +33322668230
Email schmidt.jean@chu-amiens.fr
Status Recruiting
Phase N/A
Start date July 8, 2010
Completion date July 8, 2020

See also
  Status Clinical Trial Phase
Active, not recruiting NCT00440349 - Prednisone Versus Tamoxifen in Idiopathic Retroperitoneal Fibrosis Phase 2
Recruiting NCT06065852 - National Registry of Rare Kidney Diseases
Recruiting NCT04047576 - Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Phase 2/Phase 3
Completed NCT02705638 - Treatment of IgG4-Related Disease With Revlimid and Rituximab Phase 1
Completed NCT01584388 - Rituximab in IgG4-related Disease: A Phase 1-2 Trial Phase 1/Phase 2